Global Wealth Management Investment Advisory »

Summit Therapeutics shares owned by Global Wealth Management Investment Advisory

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Global Wealth Management Investment Advisory from 13F filings

Historical chart of Global Wealth Management Investment Advisory investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Global Wealth Management Investment Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Global Wealth Management Investment Advisory

Quarter filed Position value Share count Share price at filing
2023-12-31 $5.2k 2.0k 2.61
2023-09-30 $3.7k 2.0k 1.87
2023-06-30 $5.0k 2.0k 2.51

More positions owned by Global Wealth Management Investment Advisory

Vanguard Scottsdale Fds Short Term Treas (VGSH)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vanguard Scottsdale Fds Int Term Corp (VCIT)
Apple (AAPL)
Ishares Tr 0 5yr Invt Gr Cp (SLQD)
J P Morgan Exchange Traded F Equity Premium (JEPI)
Ishares Tr Core Sp500 Etf (IVV)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core Sp Mcp Etf (IJH)
Vanguard Whitehall Fds High Div Yld (VYM)
Microsoft Corporation (MSFT)
Bank of America Corporation (BAC)
JPMorgan Chase & Co. (JPM)
Vanguard Scottsdale Fds Mtg Bkd Secs Etf (VMBS)
Ishares Tr Iboxx Hi Yd Etf (HYG)

View all positions for Global Wealth Management Investment Advisory

Top funds holding Summit Therapeutics

Vanguard Group
Charles Schwab Investment Management
Steward Partners Investment Advisory
ALPS Advisors
Barclays
Bank of New York Mellon
Jpmorgan Chase & Co
Swiss National Bank
Goldman Sachs Group
UBS Group
Advisor Group Holdings
China Universal Asset Management
Rhumbline Advisers
CSS
Bank of America Corporation

View all funds holding Summit Therapeutics